TakedaTakeda Pharmaceutical Company Limited4502東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +5.9% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | 4.6% | —× | — |
| 2019 | 6.4% | 0.23× | 1.5% | 1.73× | 2.6% |
| 2022 | — | —× | 1.7% | —× | — |
| 2023 | — | —× | 2.3% | —× | — |
| 2024 | 3.4% | 0.29× | 1.0% | 2.00× | 2.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Revenue | 1,770,531 | 2,097,224 | 3,569,006 | 4,027,478 | 4,263,762 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 217,205 | 127,612 | 302,571 | 375,090 | 52,791 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | 186,886 | 135,192 | 230,059 | 317,017 | 144,067 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥294.5B | ¥702.1B | ¥849.7B | ¥533.5B | ¥457.8B |
| Total assets | ¥4.11T | ¥13.8T | ¥13.2T | ¥14T | ¥15.1T |
| Net assets | — | ¥5.19T | — | — | ¥7.27T |
EDINET (FSA Japan)
有価証券報告書－第149期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第146期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第145期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第144期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 11 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.